TPG is fast approaching the close of its latest flagship buyout offering and affiliated healthcare fund, now only a few billion shy of their combined $17bn target. The two funds, TPG Partners X and TPG Healthcare Partners III, launched in mid-2025, have secured $14 billion as of 30 June, according to CEO Jon Winkelried. These funds are part of TPG’s $94bn Capital platform for large-scale global private equity investing. Jeff Rhodes, John Schilling, and Nehal Raj are key figures associated with TPG Capital, driving the fundraising efforts. The progress highlights TPG’s strong performance in the healthcare sector, traditionally raised in tandem with other offerings. The funds aim to capitalize on global healthcare investment opportunities, with TPG targeting a significant share of the market. Winkelried emphasized the momentum in the Q2 2026 earnings call, noting the proximity to the $17bn goal.

The $14 billion raised places TPG well ahead of similar healthcare fundraisers, reflecting investor confidence. TPG Partners X and TPG Healthcare Partners III are structured to handle large-scale investments, aligning with TPG’s strategy to dominate key sectors. The funds’ success hinges on TPG’s ability to close the remaining gap, which is expected to be finalized soon. This achievement underscores TPG’s reputation as a leader in private equity healthcare investments. The $94bn Capital platform supports such large-scale operations, enabling TPG to execute its long-term investment thesis.

With the combined target of $17bn, TPG’s healthcare funds are positioned to capture a lion’s share of the market. The $3 billion remaining to reach the target is a manageable figure, given TPG’s track record. The involvement of seasoned professionals like Rhodes, Schilling, and Raj adds credibility to the fund’s execution. TPG’s focus on healthcare aligns with global trends, making it a strategic move. The funds’ performance will likely influence TPG’s future fundraising capabilities. Investors are closely monitoring the closure to assess TPG’s market dominance. The $17bn target represents a critical milestone for TPG’s $94bn platform, signaling its scale and ambition.